Transfusion in CMV seronegative T-depleted allogeneic stem cell transplant recipients with CMV-unselected blood components results in zero CMV transmissions in the era of universal leukocyte reduction: a UK dual centre experience

HBV reactivation in allogeneic stem cell transplant recipients: risk factors, outcome and role of HBV mutations

Zeitschrift für Gastroenterologie ◽

10.1055/s-0037-1612891 ◽

2018 ◽

Vol 56 (01) ◽

pp. E2-E89 ◽

Cited By ~ 1

Author(s):

O Anastasiou ◽

F Almpani ◽

A Herrmann ◽

G Gerken ◽

M Ditschkowski ◽

...

Keyword(s):

Risk Factors ◽

Stem Cell ◽

Stem Cell Transplant ◽

Hbv Reactivation ◽

Cell Transplant ◽

Management of Allogeneic Stem Cell Transplant Recipients with Hepatic Veno-Occlusive Disease

Global Journal of Hematology and Blood Transfusion ◽

10.15379/2408-9877.2017.04.01.01 ◽

2017 ◽

Vol 4 (1) ◽

Author(s):

Alessandro Busca

Keyword(s):

Stem Cell ◽

Stem Cell Transplant ◽

Occlusive Disease ◽

Cell Transplant ◽

Common seasonal respiratory virus infections in allogeneic stem cell transplant recipients during the SARS-COV-2 pandemic

Bone Marrow Transplantation ◽

10.1038/s41409-021-01319-5 ◽

2021 ◽

Author(s):

Rosalía De la Puerta ◽

Juan Montoro ◽

Carla Aznar ◽

Ignacio Lorenzo ◽

Eva María González-Barberá ◽

...

Keyword(s):

Stem Cell ◽

Respiratory Virus ◽

Stem Cell Transplant ◽

Cell Transplant ◽

Transplant Recipients ◽

Virus Infections ◽

Respiratory Virus Infections

Utilizing Data to Modify Standard Operating Procedures and Improve Outcomes: Evaluating Complications after Donor Lymphocyte Infusions in Allogeneic Stem Cell Transplant Recipients

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2018.12.412 ◽

2019 ◽

Vol 25 (3) ◽

pp. S128-S129

Author(s):

Kimberly A. Kasow ◽

Jennifer E. Brondon ◽

Paul M. Armistead ◽

Jonathan S. Serody ◽

Benjamin G Vincent ◽

...

Keyword(s):

Stem Cell ◽

Stem Cell Transplant ◽

Standard Operating Procedures ◽

Cell Transplant ◽

Transplant Recipients ◽

Standard Operating ◽

Donor Lymphocyte Infusions

Epidemiology of Invasive Mold Infections in Allogeneic Stem Cell Transplant Recipients: Biological Risk Factors for Infection According to Time after Transplantation

Clinical Infectious Diseases ◽

10.1086/591969 ◽

2008 ◽

Vol 47 (8) ◽

pp. 1041-1050 ◽

Cited By ~ 235

Author(s):

Carol Garcia‐Vidal ◽

Arlo Upton ◽

Katharine A. Kirby ◽

Kieren A. Marr

Keyword(s):

Risk Factors ◽

Stem Cell ◽

Stem Cell Transplant ◽

Cell Transplant ◽

Transplant Recipients ◽

Biological Risk ◽

Invasive Mold Infections

Comparable humoral response after two doses of adjuvanted influenza A/H1N1pdm2009 vaccine or natural infection in allogeneic stem cell transplant recipients

Vaccine ◽

10.1016/j.vaccine.2013.11.073 ◽

2014 ◽

Vol 32 (5) ◽

pp. 585-591 ◽

Cited By ~ 16

Author(s):

Nathalie Dhédin ◽

Anne Krivine ◽

Nicole Le Corre ◽

Alain Mallet ◽

Bruno Lioure ◽

...

Keyword(s):

Stem Cell ◽

Influenza A ◽

Stem Cell Transplant ◽

Natural Infection ◽

Humoral Response ◽

Cell Transplant ◽

Whole Exome Sequencing and in silico Determination of the Magnitude of Alloreactive Antigen Presentation on HLA DRB1 in Allogeneic Stem Cell Transplant Recipients

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2016.12.339 ◽

2017 ◽

Vol 23 (3) ◽

pp. S199-S200

Author(s):

Ali Raied Salman ◽

Vishal N. Koparde ◽

Charles E. Hall ◽

David J. Kobulnicky ◽

Allison F. Scalora ◽

...

Keyword(s):

Stem Cell ◽

Exome Sequencing ◽

Whole Exome Sequencing ◽

In Silico ◽

Stem Cell Transplant ◽

Cell Transplant ◽

Transplant Recipients ◽

Whole Exome

Alternate day ganciclovir and foscarnet is safe and effective in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipients

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2005.11.419 ◽

2006 ◽

Vol 12 (2) ◽

pp. 136-137

Author(s):

E. Shereck ◽

O. Militano ◽

E. Cooney ◽

C. van de Ven ◽

Y.K.K. Cheung ◽

...

Keyword(s):

At Risk ◽

Stem Cell ◽

Stem Cell Transplant ◽

Cell Transplant ◽

Clinical Validation of Dried Blood Spot Sampling in Therapeutic Drug Monitoring of Ciclosporin A in Allogeneic Stem Cell Transplant Recipients

Therapeutic Drug Monitoring ◽

10.1097/ftd.0b013e31827d76ce ◽

2013 ◽

Vol 35 (1) ◽

pp. 92-95 ◽

Cited By ~ 18

Author(s):

Abraham J. Wilhelm ◽

Adinda Klijn ◽

Jeroen C. G. den Burger ◽

Otto J. Visser ◽

Agnes I. Veldkamp ◽

...

Keyword(s):

Stem Cell ◽

Therapeutic Drug Monitoring ◽

Stem Cell Transplant ◽

Therapeutic Drug ◽

Cell Transplant ◽

Clinical Validation ◽

Transplant Recipients ◽

Ciclosporin A ◽

Blood Spot

Transfusion of CMV-unselected blood components may lead to inappropriate donor selection for patients subsequently undergoing allogeneic stem cell transplant

Transfusion Medicine ◽

10.1111/tme.12264 ◽

2015 ◽

Vol 25 (6) ◽

pp. 411-413 ◽

Cited By ~ 4

Author(s):

S. Morton ◽

R. Danby ◽

V. Rocha ◽

A. Peniket ◽

M. F. Murphy

Keyword(s):

Stem Cell ◽

Stem Cell Transplant ◽

Donor Selection ◽

Cell Transplant ◽

Blood Components ◽

Selection For